Pharmabiz4h
Sobi & Apellis Pharma announces EMA validates indication extension application for Aspaveli for treatment of C3G and primary IC-MPGN
Stockholm, Sweden Saturday, February 22, 2025, 09:00 Hrs [IST] ...
Pharmaceutical Excipients Market Revenue Statistics Register 7.03% CAGR By Global Demands, Size, Developments During 2025 to 2032
Pharmaceutical Excipients Market Competitive Research and Growth Analysis by Function (Pharmaceutical Fillers, Binders, Coatings, Disintegrants, Preservatives, Others), Application (Oral, Parenteral, ...
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ...
Gilead’s Seladelpar gets European Marketing Authorization for liver disease treatment
Gilead Sciences (GILD) said on Friday that the European Commission (EC) granted conditional marketing authorization for ...
Pound Sterling weakens against US Dollar as investors see Trump tariffs less fearful
The Pound Sterling gains sharply against its major peers after the release of upbeat UK Retail Sales data for January. UK’s ...
PMLiVE19h
EC approves Biocon’s Stelara biosimilar Yesintek for inflammatory diseases
The European Commission (EC) has approved Biocon Biologics’ Yesintek, an ustekinumab biosimilar referencing Johnson & Johnson’s Stelara, to treat multiple inflammatory diseases.
centerforbiosimilars19h
The Top 5 Biosimilar Articles for the Week of February 17
Number 4: The FDA and European Medicines Agency (EMA) granted approval, with interchangeability in the US, to Samsung Bioepis ...
US Dollar Index Price Forecast: Tests 106.50 near descending channel's lower boundary
On the downside, the US Dollar Index may test the lower boundary of the descending channel at 106.10, followed by the key psychological level of 106.00. A break below this critical support zone could ...